Redefining the Future of Medicine
with sustainable health solutions with fewer side effects.
About Us
Stramsen Biotech
Our Vision
Stramsen Biotech is to pioneer transformative therapeutic solutions that bridge the gap between complex medical challenges and life-changing patient outcomes. We are dedicated to harnessing the power of cutting-edge biotechnology to develop innovative pharmaceuticals that address critical unmet needs in global healthcare. By prioritizing rigorous scientific excellence and a patient-centric approach, we aim to redefine the standards of modern medicine.
Our Approach
Stramsen Biotech's plant-based medicine approach blends scientific expertise with technological advancements to tackle healthcare challenges. We aim to push boundaries, explore new frontiers, and deliver solutions that can revolutionize the biomedical industry with minimum side effects.
Our focus
Pipeline of 33 Drug Candidates
Wound Care
SBX-1977 is a novel, plant-based botanical wound care drug candidate. SBX1977 is our lead drug candidates.
Prostaste Cancer
SBX 1052: Designed to control and prevent the enlargement of the prostate gland
General Oncology
Our SBX 2021: Drug candidate Controls and prevents the proliferation and metastasis of various cancer cells.
High Blood Pressure
SBX-2000 is our plant-based therapeutic candidate designed for the management of various cardiovascular diseases.
